BioSpace News Archive

NEW YORK, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or “the Company”), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced that management will present at two upcoming conferences: SVB Leerink 9 th Annual Global Healthcare Conference on Thursday, February 27, 2020, fireside chat at 9:00 a.m. ET in New York, NY Cowen and Company 40 th Annual

Philanthropic Tej Kohli Foundation will establish a new incubator to back scientific projects and commercial ventures that are targeting new solutions.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that, due to strong demand, it has increased its previously announced non-brokered private placement of units (the “Units”), and has issued an aggregate of 18,304,939 Units at the price of CDN$0.085 per Unit, raising gross proceeds of CDN$1,555,919.82 (the “Offering”).

Research Supported by Bay Area Lyme Foundation Evaluates Anti-microbial Effects of 14 Natural Products Compared to Antibiotics Used to Treat Lyme Disease [21-February-2020] MARIN, Calif. , Feb. 21, 2020 /PRNewswire/ -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data finding that seven herb

Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has now successfully completed its Series B financing having raised a total of $19.0 million from current and new institutional investors since commencement of the round in July 2018.

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will attend in the 9th Annual SVB Leerink Global Healthcare Conference at the Lotte New York Palace in New York, New York

-- Cigna brings together World Champion Michael Phelps and 19th Surgeon General of the United States Dr. Vivek Murthy to address loneliness and depression

SAN JOSE, Calif. , Feb. 21, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2019 after the close of

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that Tom Kassberg, the company’s Chief Business Officer, will present at the SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020 at 11:00 AM ET in New York, NY.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report fourth quarter 2019 and 2019 financial results for the period ended December 31, 2019, following the close of the market on Thursday, March 26, 2020.